NeuroLutions
[PRIVATE]Service & Cobot Robotics · HQ: St. Louis, Missouri · Est. 2007 · 1 model registered · 2 deployments
As of Sep 2026, DEPLOY verifies NeuroLutions: 1 model, 2 deployments across 2 regions. 1 source back the record.
Ownership
PRIVATE
Capital / Funding
Undisclosed
Headquarters
St. Louis, Missouri
IP / Patents
Undisclosed
Platform Models
1
Audited Incidents
0
Overview
NeuroLutions (now merged into Kandu, Inc.) developed the IpsiHand System, the first FDA-cleared brain-computer interface device for stroke rehabilitation. The wearable BCI translates brain signals from the uninjured hemisphere into hand movement. In 2024, CMS created a dedicated Medicare reimbursement code — the first for any BCI device. Merged with Kandu Health in 2025 with 0M financing.
Clean safety record across 2 verified deployments. Limited public funding data for capital position assessment.
Key Facts
Safety & Regulatory Posture
No incidents on record for NeuroLutions.
Leadership & Founders
Current Program Leadership & Executives
CEO
Co-founder & Chief Scientific Officer
Founding Team
cofounder · no longer at company
Partnerships & Commercial Deployments
Operator Customers & Fleet Integrators
Platform Models
Deployments
Sectors & Applications
FAQ
What is NeuroLutions?
NeuroLutions (now merged into Kandu, Inc.) developed the IpsiHand System, the first FDA-cleared brain-computer interface device for stroke rehabilitation. The wearable BCI translates brain signals from the uninjured hemisphere into hand movement. In 2024, CMS created a dedicated Medicare reimbursement code — the first for any BCI device. Merged with Kandu Health in 2025 with 0M financing.
What does NeuroLutions make?
NeuroLutions has 1 robot model on the DEPLOY registry: IpsiHand (NeuroLutions builds physical robots).
Is NeuroLutions publicly traded?
No. NeuroLutions is privately held and not publicly traded, per the DEPLOY registry.
Who competes with NeuroLutions?
On the DEPLOY registry, peer companies to NeuroLutions building in the same form factors include Google, Samsung Electronics, Butterfly Network, Abbott.
Who is the CEO of NeuroLutions?
Leo Petrossian is the ceo of NeuroLutions, per the DEPLOY registry.
How can I invest in NeuroLutions?
NeuroLutions is a private company; its shares are not available on public markets, so retail investors cannot buy the stock today.
Where is NeuroLutions headquartered?
NeuroLutions is headquartered in St. Louis, Missouri, USA.
Who owns NeuroLutions?
NeuroLutions is privately held; ownership sits with its founders and private investors.
Where does NeuroLutions operate robots?
NeuroLutions operates 2 verified deployments, including at United States (multiple hotel chains), Germany, Europe.
How many robots has NeuroLutions deployed?
DEPLOY has 2 verified NeuroLutions deployments on record at sites including United States (multiple hotel chains), Germany, Europe. That is a count of distinct field deployments each backed by sourced evidence, not a manufacturer's claimed unit total; it updates as new sites are verified.
Is NeuroLutions a top robotics company?
On DEPLOY's intelligence score, which blends verified deployments, funding, hiring, media, safety, and IP signals, NeuroLutions ranks in roughly the top 86% of companies tracked by the registry.
When was NeuroLutions founded?
NeuroLutions was founded in 2007.
Is NeuroLutions safe?
NeuroLutions has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.